Recombinant protein therapeutics—success rates, market trends and values to 2010
Alex K Pavlou1
& Janice M Reichert2
1
Alex K Pavlou is at Datamonitor plc., Charles House 108-110 Finchley Road, London, NW3 5JJ apavlou@datamonitor.com.
2
Janice M Reichert is at Tufts Center for the Study of Drug Development, 192 South Street, Suite 550, Boston, Massachusetts 02111, USA janice.reichert@tufts.edu
Despite entering its maturation phase, the recombinant protein sector will continue to drive the growth of medical biotechnology over the next six years.
